AGK2

产品说明书

Print
Chemical Structure| 304896-28-4 同义名 : -
CAS号 : 304896-28-4
货号 : A480363
分子式 : C23H13Cl2N3O2
纯度 : 99%+
分子量 : 434.27
MDL号 : MFCD01909444
存储条件：

Pure form Sealed in dry, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月
溶解度 : -
动物实验配方：

8% DMSO+30% PEG 300+water 1.4 mg/mL

生物活性
靶点

  • SIRT2

    SIRT2, IC50:3.5 μM

  • SIRT2

    SIRT2, IC50:3.5 μM
描述 AGK2 acts as a selective inhibitor for SIRT2, demonstrating an IC50 value of 3.5 μM. It also inhibits SIRT1 and SIRT3, with respective IC50 values of 30 μM and 91 μM[1]. AGK2 markedly suppresses cell multiplication in correlation with the dosage. Additionally, AGK2 curtails cell expansion dose-dependently while not triggering cytotoxic effects at lower concentrations. Following a 12-day period of AGK2 treatment at 5 μM, there is a notable decline in the colony-forming capability of cells in soft agar to 46% compared to control cells. Western blot results indicate a dose-dependent reduction in the levels of CDK4, CDK6, and cyclin D1 post-AGK2 treatment. AGK2 also downregulates the expression of the p53 protein[2]. Exposing microglial BV2 cells to AGK2 at a concentration of 10 μM results in a considerable elevation of PAR signals. This treatment also causes a notable reduction in intracellular ATP levels and a significant rise in both advanced apoptosis and cell necrosis[3].
细胞研究
细胞系 浓度 检测类型 检测时间 活性说明 数据源
Escherichia coli BL21 (DE3) cells Function assay Inhibition of full length human SIRT2 expressed in Escherichia coli BL21 (DE3) cells using fluorogenic 7-amino-4-methylcoumarin (AMC)-labeled peptide by fluorescence assay, IC50=1.56 μM 25275824
H4 cells Function assay 24 h Inhibition of SIRT2 in H4 cells co-transfected with alphaSyn and synphilin1 assessed as enlarged alphaSyn inclusions after 24 hrs 17588900
HeLa cells Function assay Inhibition of over-expressed SIRT2 immunoprecipitated from HeLa cells transfected with SIRT2-myc expression construct 17588900
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.30mL

0.46mL

0.23mL

11.51mL

2.30mL

1.15mL

23.03mL

4.61mL

2.30mL
参考文献

[1]He X, Nie H, et al. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun. 2012 Jan 6;417(1):468-72.

[2]Outeiro TF, Kontopoulos E, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 2007 Jul 27;317(5837):516-9. Epub 2007 Jun 21.